Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 22Unknown 12Recruiting 7Terminated 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 3

Interventions

Trastuzumab 86Cyclophosphamide 67Capecitabine 67Paclitaxel 63Docetaxel 57Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 40Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 18atezolizumab 17Everolimus 17130-nm albumin-bound paclitaxel 17pertuzumab 16Epirubicin 16palbociclib 15eribulin 14Magnetic Resonance Spectroscopy 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Control Groups × Breast × Clear all
NCT04385433 2023-08-24

PRAVAPREV-01

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Terminated
15 enrolled
Breast

Breast Neoplasms

NCT02433067 2020-10-06

CARDAPAC

University of Franche-Comté

Phase NA Terminated
89 enrolled
Breast

Breast Neoplasms

NCT00610467 2020-04-20

Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis

University of California, Irvine

Phase NA Terminated
2 enrolled 4 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡